ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Clin Pharmacol Biopharm 2023, Vol 12(10): 383

Assessment of the Prescribing Pattern of Drugs in Chronic Kidney Disease Patients in a Tertiary Care Hospital

Aasim Yousoof1*, Rakendra Singh2, Mohammad Talat Ul Tuba Dar3, Ansar Ahmad Paray4 and Md Chand1
1Adesh Institute of Pharmacy and Biomedical Sciences, Adesh University, Bathinda, India
2Department of General Medicine, Adesh Institute of Medical Sciences and Research, Adesh University, Bathinda, India
3College of Paramedical Sciences, Adesh University, Bathinda, India
4Centre for Interdisciplinary and Biomedical Research, Adesh University, Bathinda, India
*Corresponding Author : Aasim Yousoof, Adesh Institute of Pharmacy and Biomedical Sciences, Adesh University, Bathinda, India, Email: asimyusufbph@gmail.com

Received Date: Oct 02, 2023 / Accepted Date: Oct 26, 2023 / Published Date: Oct 27, 2023

Abstract

Objectives: To study the prescription pattern of drugs in chronic kidney disease (CKD) patients attending a tertiary care hospital.

Materials and methods: This prospective observational study was conducted at a tertiary care hospital in patients with chronic kidney disease. Patient demographic details, clinical profile, drug usage pattern was recorded using medication usage form and structured case report form and data were analysed using statistical software. Drug-drug interactions were checked using Lexicomp.

Results: A total of 60 patients recruited over a period of 3 months were included in the study and data was obtained. Mean age was 59 years. 63% were males and 37% were females. 52% were in stage 4 of chronic kidney disease [1]. Hypertension (64.9%) was most common comorbidity present followed by anaemia (61.4%), and diabetes (52.6%). A total number of 686 drugs were prescribed in 60 prescriptions. Median number of drugs prescribed per prescription was 11.43 Major classes of drugs prescribed were cardiovascular drugs (23.61%), haematopoietic agents (23.03%), gastrointestinal drugs (9.76%), multivitamins and Minerals (16.32%), anti-hypertensive drugs (11%), antibiotics (6.55%). Potential drug-drug interaction per prescription was 3.18. Out of total 686 drugs, 137 drugs were prescribed by generic name.

Conclusion: Due to multiple comorbidities associated with chronic kidney disease patients, large number of drugs were prescribed indicative of polypharmacy. Potential Drug-drug interactions were also significantly high in these patients. A large number of drugs were prescribed by generic name.

Citation: Yousoof A, Singh R, Dar MTT, Paray AA, Chand M (2023) Assessment ofthe Prescribing Pattern of Drugs in Chronic Kidney Disease Patients in a TertiaryCare Hospital. Clin Pharmacol Biopharm, 12: 383.

Copyright: © 2023 Yousoof A, et al. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top